Interferon-Alpha Plus Sorafenib Combination Shows Efficacy and Improved Patient Outcome in Renal Cell Cancer

Cancer Biology and Therapy - United States
doi 10.4161/cbt.6.8.5011
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited